O2 RegenTech is commercializing cost-effective, easy-to-use wound care solutions.
O2 RegenTech has raised $250K in total funding. The most recent round was Seed. The last funding was announced in July 2021.
O2 RegenTech's investors include National Science Foundation, MassChallenge, JumpStart Inc., Newchip Accelerator, National Institutes of Health.
O2 RegenTech is headquartered in Akron, United States.
O2 RegenTech is commercializing cost-effective, easy-to-use wound care solutions.
O2 RegenTech is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"O2 RegenTech — Funding & Investors." VCBacked, July 30, 2021, https://www.vcbacked.co/company/o2-regentech. Accessed August 15, 2026.
VCBacked. (2021). O2 RegenTech — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/o2-regentech
{{cite web |title=O2 RegenTech — Funding & Investors |url=https://www.vcbacked.co/company/o2-regentech |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated